FMT
SGMO

First Mercantile Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Mercantile Trust’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,581
Closed -$56K – 883
2020
Q4 		$56K Sell
3,581
-296
-8% -$3.47K 0.01% 779
2020
Q3 		$45K Sell
3,877
-984
-20% -$10.6K 0.01% 789
2020
Q2 		$44K Sell
4,861
-135
-3% -$1.25K 0.01% 781
2020
Q1 		$32K Sell
4,996
-186
-4% -$1.38K ﹤0.01% 763
2019
Q4 		$43K Sell
5,182
-419
-7% -$3.85K 0.01% 809
2019
Q3 		$51K Sell
5,601
-138
-2% -$1.55K 0.01% 813
2019
Q2 		$62K Sell
5,739
-509
-8% -$5.41K 0.01% 736
2019
Q1 		$60K Sell
6,248
-267
-4% -$2.73K 0.01% 754
2018
Q4 		$75K Sell
6,515
-474
-7% -$5.89K 0.02% 719
2018
Q3 		$118K Sell
6,989
-339
-5% -$5.15K 0.02% 665
2018
Q2 		$104K Sell
7,328
-338
-4% -$5.62K 0.02% 710
2018
Q1 		$146K Buy
7,666
+3,708
+94% +$79.3K 0.03% 584
2017
Q4 		$65K Sell
3,958
-653
-14% -$9.71K 0.01% 764
2017
Q3 		$69K Sell
4,611
-76
-2% -$840 0.01% 757
2017
Q2 		$41K Sell
4,687
-1,654
-26% -$10.6K 0.01% 796
2017
Q1 		$33K Sell
6,341
-468
-7% -$1.88K 0.01% 800
2016
Q4 		$21K Sell
6,809
-633
-9% -$2.31K ﹤0.01% 815
2016
Q3 		$34K Sell
7,442
-686
-8% -$3.49K ﹤0.01% 800
2016
Q2 		$47K Sell
8,128
-568
-7% -$3.62K 0.01% 835
2016
Q1 		$53K Sell
8,696
-910
-9% -$5.46K 0.01% 822
2015
Q4 		$88K Hold
9,606
– – 0.01% 841
2015
Q3 		$54K Buy
9,606
+578
+6% +$4.77K 0.01% 916
2015
Q2 		$100K Hold
9,028
– – 0.01% 868
2015
Q1 		$142K Buy
9,028
+1,089
+14% +$16.9K 0.01% 765
2014
Q4 		$121K Sell
7,939
-718
-8% -$8.72K 0.01% 803
2014
Q3 		$93K Sell
8,657
-10,259
-54% -$134K 0.01% 904
2014
Q2 		$289K Buy
18,916
+11,190
+145% +$161K 0.02% 652
2014
Q1 		$140K Buy
+7,726
New +$149K 0.01% 868

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Mercantile Trust's SGMO Position: Q1 2021 in Review

First Mercantile Trust sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 3,581 shares — an estimated $56K sold.

First Mercantile Trust first reported a position in SGMO in Q1 2014 and held it in 28 quarters. The position peaked at $289K in Q2 2014. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • First Mercantile Trust reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • First Mercantile Trust sold 3,581 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $56K.
  • First Mercantile Trust first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 28 quarters.
  • First Mercantile Trust's SANGAMO THERAPEUTICS INC position peaked at $289K in Q2 2014.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on First Mercantile Trust's 13F filing for Q1 2021, filed 14 May 2021.